List of pharmaceutical companies
From Wikipedia, the free encyclopedia
(Redirected from Pharmaceuticals industry)
|
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
The following is a list of the twelve largest healthcare companies ranked here by revenue as of March 2010[update] according to their released 2009 annual reports.
| Rank | Company | Country | Total Revenues (USD billions) | Total Revenues (reported currency in millions) | Change 09/08 (%) | Net income/ (loss) (reported currency in millions) | Change 09/08 (%) | R&D Expenses (reported currency in millions) | Change 09/08 (%) | Fortune 500 Ranking[1] |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & Johnson[2] | United States | 61.90[3] | $61,897 | -2.9 | $12,266 | -5.3 | 6,986 | -7.8 | 103 |
| 2 | Pfizer[4] | United States | 50.01[3] | $50,009 | 3.5 | 8,635 | 6.6 | 7,845 | -1.3 | 152 |
| 3 | Roche[5] | Switzerland | 47.35[3] | 49,051 CHF | 7.5 | 8,510 CHF | -21.5 | 9,874 CHF | 11.6 | 171 |
| 4 | GlaxoSmithKline[6] | United Kingdom | 45.83[3] | £28,368 | 16.5 | £5,669 | 20.3 | £4,106 | 11.5 | 168 |
| 5 | Novartis[7] | Switzerland | 44.27[3] | $44,267 | 6.8 | $8,454 | 3.6 | $7,469 | 3.5 | 183 |
| 6 | Sanofi[8] | France | 41.99[3] | €29,306 | 6.3 | €8,471 | 17.9 | €4,583 | 0.2 | 181 |
| 7 | AstraZeneca[9] | UK/Sweden | 32.81[10] | $32,804 | 3.8 | $7,544 | 23.1 | $4,409 | -14.9 | 268 |
| 8 | Abbott Laboratories[11] | United States | 30.76[10] | $30,765 | 4.2 | 5,746 | 21.4 | 2,744 | 2.1 | 294 |
| 9 | Merck & Co.[12] | United States | 27.43[10] | $27,428 | 15.0 | $13,024 | 64.2 | $5,800 | 20.8 | 378 |
| 10 | Bayer HealthCare[13] | Germany | 22.30 | €15,988 | 3.8 | €1,696 | 38.8 | €1,845 | 5.9 | 154 |
| 11 | Eli Lilly[14] | United States | 21.84[15] | $21,836 | 7.2 | $4,328 | N/A | N/A | N/A | 455 |
| 12 | Bristol-Myers Squibb[16] | United States | 18.81[17] | $18,808 | 6.2 | $4,420 | 19.9 | 3,647 | 3.8 | 435 |
Some data have not been audited yet. Bayer has additional revenue not included here. The missing parts of the table will be added as more data are released by the companies.
The following is a list of the twelve largest healthcare companies ranked by revenue as of July 2009[update] in the Fortune Global 500.[1]
| Rank[1] | Company | Country | Total Revenues (USD millions) | Net income/ (loss) (USD millions) | Employees |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | United States | 63,747.0[18] | 12,949.0 | 118,700 |
| 2 | Pfizer | United States | 48,296.0[19] | 8,104.0 | 81,800 |
| 3 | GlaxoSmithKline | United Kingdom | 44,654.0[20] | 8,438.6 | 99,003 |
| 4 | Roche | Switzerland | 44,267.5[21] | 8,288.1 | 80,080 |
| 5 | Sanofi-Aventis | France | 42,179.0[22] | 5,636.7 | 98,213 |
| 6 | Novartis | Switzerland | 41,459.0[23] | 8,195.0 | 96,717 |
| 7 | AstraZeneca | United Kingdom/Sweden | 31,601.0[24] | 6,101.0 | 65,000 |
| 8 | Abbott Laboratories | United States | 29,527.6[25] | 4,880.7 | 68,838 |
| 9 | Merck | United States | 23,850.3[26] | 7,808.4 | 55,200 |
| 10 | Wyeth | United States | 22,833.9[27] | 4,417.8 | 47,426 |
| 11 | Bristol-Myers Squibb | United States | 21,366.0[28] | 5,247.0 | 35,000 |
| 12 | Eli Lilly | United States | 20,378.0[29] | (2,071.9) | 40,500 |
The following is a list of the 49 largest companies involved in pharmaceutical and biotech industry ranked by healthcare revenue as of 2008[update].[30] Some companies (e.g., Bayer) has additional revenue not included here.[31][32]
| Rank[30] | Company | Country | Total Revenues (USD millions) | Healthcare R&D 2008 (USD millions) | Net income/ (loss) 2008 (USD millions) | Employees 2008 |
|---|---|---|---|---|---|---|
| 1 | Pfizer[33] (with Wyeth[34]) | United States | 70,696 | 11,318 | 14,111 | 137,127 |
| 2 | Johnson & Johnson | United States | 63,747 | NA | 10,576 | 119,200 |
| 3 | Hoffmann–La Roche | Switzerland | 43,970 | NA | 8,135 | 78,604 |
| 4 | Novartis | Switzerland | 41,460 | NA | 11,946 | 98,200 |
| 5 | GlaxoSmithKline | United Kingdom | 40,424 | 6,373 | 10,432 | 103,483 |
| 6 | Sanofi-Aventis | France | 40,328 | NA | 7,204 | 99,495 |
| 7 | AstraZeneca | United Kingdom/Sweden | 31,601 | NA | 5,959 | 67,400 |
| 8 | Abbott Laboratories[35] | United States | 29,527 | 2,688 | 4,880 | 68,697 |
| 9 | Merck & Co. | United States | 23,850 | 4,678 | 7,808 | 74,372 |
| 10 | Bristol-Myers Squibb | United States | 19,977 | NA | 2,165 | 42,000 |
| 11 | Eli Lilly and Company | United States | 18,634 | NA | 2,953 | 40,600 |
| 12 | Boehringer Ingelheim | Germany | 16,959 | 1,977 | 2,163 | 43,000 |
| 13 | Takeda Pharmaceutical Co. | Japan | 15,697 | 1,620 | 2,870 | 15,000 |
| 14 | Bayer [36] | Germany | 15,407 | 3,770 | 6,448 | 108,600 |
| 15 | Amgen | United States | 14,771 | 3,366 | 3,166 | 48,000 |
| 16 | Genentech | United States | 13,400 | 15773 | 3,640 | 33,500 |
| 17 | Baxter International | United States | 12,300 | 614 | 1,397 | 38,428 |
| 18 | Teva Pharmaceutical Industries | Israel | 11,080 | 495 | 546 | 26,670 |
| 19 | Astellas Pharma | Japan | 10,701 | 1,435 | 1,122 | 23,613 |
| 20 | Daiichi Sankyo | Japan | 9,682 | 1,459 | 671 | 20,100 |
| 21 | Novo Nordisk | Denmark | 9,081 | 1,063 | 1,922 | 26,575 |
| 22 | Procter & Gamble | United States | 8,964 | NA | 10,340 | 29,258 |
| 23 | Eisai | Japan | 5,583 | 926 | 604 | 14,993 |
| 24 | Merck KGaA | Germany | 5,175 | 772 | 1,258 | 13,900 |
| 25 | Alcon | United States | 4,897 | 512 | 1,348 | 13,500 |
| 26 | SINOPHARM | China | 4,700 | 498 | 1249 | 9700 |
| 27 | Akzo Nobel | Netherlands | 4,694 | 741 | 1,449 | 13,000 |
| 28 | UCB | Belgium | 4,426 | 1,024 | 492 | 12,741 |
| 29 | Nycomed | Switzerland | 4,264 | NA | -105 | 10,533 |
| 30 | Forest Laboratories | United States | 3,442 | 941 | 454 | 9,649 |
| 31 | Solvay | Belgium | 3,268 | 533 | 1,026 | 9,000 |
| 32 | Genzyme | United States | 3,187 | 650 | -17 | 8,477 |
| 33 | Allergan | United States | 3,063 | 1,056 | -127 | 8,423 |
| 34 | Gilead Sciences | United States | 3,026 | 384 | -1,190 | 6,772 |
| 35 | CSL | Australia | 2,788 | 161 | 454 | 6,400 |
| 36 | Chugai Pharmaceutical Co. | Japan | 2,787 | 467 | 328 | 5,962 |
| 37 | Biogen Idec | United States | 2,683 | 718 | 218 | 5,907 |
| 38 | Bausch & Lomb | United States | 2,292 | 197 | 15 | 5,830 |
| 39 | Taiho Pharmaceutical Co. | Japan | 2,069 | 244 | 132 | 5,756 |
| 40 | King Pharmaceuticals | United States | 1,989 | 254 | 289 | 5,191 |
| 41 | Watson Pharmaceuticals | United States | 1,979 | 131 | -445 | 5,126 |
| 42 | Mitsubishi Pharma | Japan | 1,945 | 403 | 208 | 5,111 |
| 43 | Shire | United Kingdom | 1,797 | 387 | 278 | 4,958 |
| 44 | Cephalon | United States | 1,764 | 403 | 145 | 4,913 |
| 45 | Dainippon Sumitomo Pharma | Japan | 1,763 | 350 | 193 | 3,750 |
| 46 | Kyowa Hakko | Japan | 1,698 | 268 | 108 | 2,895 |
| 47 | Shionogi | Japan | 1,640 | 320 | 159 | 2,868 |
| 48 | Mylan Laboratories | United States | 1,612 | 104 | 217 | 2,800 |
| 49 | H. Lundbeck | Denmark | 1,552 | 329 | 186 | 2,515 |
Contents |
[edit] Alphabetical listing
- It is limited to those companies notable enough to have articles in Wikipedia.
[edit] 1-A
- 3M Pharmaceuticals
- Abbott Laboratories
- Actavis
- Actelion
- Alcon
- Alkaloid
- Alkermes
- Allergan
- Almirall
- Alphapharm, a wholly owned subsidiary of Mylan Inc.
- Altana Pharma AG, formerly part of Altana AG, part of the Nycomed Group.
- Amgen
- Amico Laboratories
- Anavex Life Sciences
- Apotex Inc.
- Astellas Pharma
- AstraZeneca
- Avax Technologies
- Axcan Pharma
- CinnaGen
[edit] B-D
- Bargn Farmaceutici Phils Co
- Barr
- Bausch & Lomb
- Baxter International
- Bayer Schering Pharma AG
- Beximco Pharmaceuticals Ltd
- Bial
- Biogen Idec, merger of Biogen and Idec Pharmaceuticals.
- Biolex
- Bionovo
- Biotecnol
- Biovail
- Biovitrum
- Boehringer-Ingelheim
- Bosnalijek
- Bristol-Myers Squibb
- Cadila Healthcare
- Celgene
- Cephalon
- Chugai Pharmaceutical Co.
- Cipla
- Covance
- Covidien
- Crucell
- CSL Limited
- Daiichi Sankyo
- Dainippon Sumitomo Pharma
- Dawakhana Shifaul Amraz
- Debiopharm
- Diabetology Ltd
- Dr. Reddy's Laboratories
- Dyson Research Laboratories
- Batco lac pharma ceuiticals ltd
[edit] E-J
- Ego Pharmaceuticals
- Eisai (company)
- Élan Corporation
- Eli Lilly and Company
- Elorac, Inc.
- Emergent BioSolutions
- Elder Pharmaceutical Ltd.
- Eskayef Bangladesh Limited
- F. Hoffmann–La Roche Ltd., which owns Genentech and Chugai Pharmaceuticals
- Ferozsons Laboratories
- Ferring Pharmaceuticals
- Forest Laboratories
- Fresenius Medical Care
- Galapagos NV
- Galderma Laboratories
- Genentech, a subsidiary of Hoffmann-La Roche
- Genzyme
- Goodwin Biotechnology
- Gulf Pharmaceutical Industries (Julphar)
- Getz Pharma
- Gilead Sciences
- GlaxoSmithKline
- GPC Biotech
- Hetero Drugs
- Hexal Australia
- Hikma Pharmaceuticals
- Hoffmann–La Roche
- Hospira
- IMULAN BioTherapeutics, LLC
- Institute for OneWorld Health
- Intas Biopharmaceuticals
- Intercytex
- Interphil Laboratories
- Janssen Pharmaceutica Products, a subsidiary of Johnson & Johnson
- Jenapharm, a subsidiary of Bayer Schering Pharma
- JN-International Medical Corporation
- Johnson & Johnson
[edit] K-L
[edit] M
[edit] N
[edit] O
- Orion Pharma
- Ortho-McNeil Pharmaceutical, a subsidiary of Johnson & Johnson
- Otsuka Pharmaceutical Co.
- Orion pharma bangladesh
[edit] P
- Panacea Biotec Ltd
- Patheon
- Par Pharmaceutical
- Perrigo
- Pfizer
- Pharmacosmos
- Pharma Nord
- Pierre Fabre Group
- Piramal Healthcare
- Pliva
- Procter & Gamble
- Purdue Pharma
[edit] R
- Ranbaxy Laboratories, generics arm of Daiichi Sankyo
- Renovo
- Respa Pharmaceuticals
- Rubicon Research
[edit] S
- Sanofi-Aventis
- Square Pharmaceuticals
- Schering-Plough
- Sepracor
- Servier Laboratories
- Shionogi
- Shire plc
- Sigma Pharmaceuticals
- Sinopharm Group
- Solvay Group
- STADA Arzneimittel
- Strides Arcolab
- Sun Pharmaceutical
- Square Pharmaceuticals
[edit] T
- Taiho Pharmaceutical
- Takeda Pharmaceutical Company
- TAP Pharmaceutical Products, a joint-venture of Abbott and Takeda.
- Temmler
- Teva Pharmaceutical Industries
- Torrent Pharmaceuticals
[edit] U-Z
- UCB
- UNILAB, also known as United Laboratories
- Valeant Pharmaceuticals International, formerly ICN Pharmaceuticals.
- Veloxis Pharmaceuticals
- Vertex Pharmaceuticals
- Vion Pharmaceuticals, Inc.
- ViroPharma
- Warner Chilcott
- Watson Pharmaceuticals
- Wockhardt
- Wyeth, a subsidiary of Pfizer
- Zandu Pharmaceuticals
- Zentiva
[edit] See also
- EuropaBio, the European Association for Bioindustries
- European Confederation of Pharmaceutical Entrepreneurs
- European Federation of Pharmaceutical Industries and Associations (EFPIA)
- History of pharmacy
- International Federation of Pharmaceutical Manufacturers and Associations
- List of biotechnology companies
- List of pharmaceutical manufacturers in the UK
- Pharmaceutical Research and Manufacturers of America (PhRMA)
[edit] References
- ^ a b c "Fortune Global 500 2009 Pharmeceutical Industry". Fortune 160 (2). July 2009. http://money.cnn.com/magazines/fortune/global500/2009/industries/21/index.html. Retrieved 2009-12-18.
- ^ Johnson & Johnson Reports 2009 Fourth-Quarter and Full-Year Results. 2010. http://www.jnj.com/connect/news/financial/20100125_130000. Retrieved 2010-03-02.
- ^ a b c d e f The Global 2000. 2010. http://www.forbes.com/lists/2010/18/global-2000-10_The-Global-2000_Sales_2.html. Retrieved 2010-08-15.
- ^ 2009 Pfizer Financial Report. 2010. http://www.pfizer.com/investors/financial_reports/financial_reports.jsp. Retrieved 2010-03-02.
- ^ 09 Roche in Brief. 2010. http://www.roche.com/rib_2009.pdf. Retrieved 2010-03-02.
- ^ Annual Reports. 2010. http://www.gsk.com/investors/annual-reports.htm. Retrieved 2010-03-02.
- ^ Annual Report 2009. 2010. http://ir2.flife.de/data/novartis2009/igb_html/index.php?bericht_id=1000002&index=1&lang=ENG. Retrieved 2010-03-02.
- ^ Annual Results 2009. 2010. http://en.sanofi-aventis.com/investors/events/corporate/2010/2010-02-10_results_2009.asp. Retrieved 2010-03-02.
- ^ Condensed Consolidated Statement of Comprehensive Income. 2010. http://www.astrazeneca.com/_mshost3690701/content/resources/media/investors/8270994/figures-fy09.pdf. Retrieved 2010-03-02.
- ^ a b c The Global 2000. 2010. http://www.forbes.com/lists/2010/18/global-2000-10_The-Global-2000_Sales_3.html. Retrieved 2010-08-15.
- ^ Annual Report 2009. 2010. http://www.abbott.com/annual-reports/2009/index.html. Retrieved 2010-04-29.
- ^ Merck Announces Fourth-Quarter and Full-Year 2009 Financial Results. Merck & Co.. 2009-07-20. http://www.merck.com/newsroom/news-release-archive/financial/2010_0216.html. Retrieved 2010-02-12.
- ^ Annual Report 009. 2010. http://www.annualreport2009.bayer.com/en/homepage.aspx. Retrieved 2010-03-02.
- ^ Lilly Reports Fourth-Quarter and Full-Year 2009 Results. 2010. http://newsroom.lilly.com/releasedetail.cfm?ReleaseID=441003. Retrieved 2010-03-02.
- ^ The Global 2000. 2010. http://www.forbes.com/lists/2010/18/global-2000-10_The-Global-2000_Sales_4.html. Retrieved 2010-08-15.
- ^ 2009 Annual Report. 2010. http://thomson.mobular.net/thomson/7/3058/4163/document_0/BMS_AR09.pdf. Retrieved 2010-04-29.
- ^ The Global 2000. 2010. http://www.forbes.com/lists/2010/18/global-2000-10_The-Global-2000_Sales_5.html. Retrieved 2010-08-15.
- ^ "Johnson & Johnson - JNJ". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/235.html. Retrieved 2010-02-12.
- ^ "Pfizer - PFE". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/324.html. Retrieved 2010-02-12.
- ^ "GlaxoSmithKline - GSK". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/6782.html. Retrieved 2010-02-12.
- ^ "Roche Group - RHHVF". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/6798.html. Retrieved 2010-02-12.
- ^ "Sanofi-Aventis - SNY". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/11156.html. Retrieved 2010-02-12.
- ^ "Novartis - NVS". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/6799.html. Retrieved 2010-02-12.
- ^ "AstraZeneca - AZN". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/10022.html. Retrieved 2010-02-12.
- ^ "Abbott Laboratories - ABT". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/4.html. Retrieved 2010-02-12.
- ^ "Merck - MRK". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/280.html. Retrieved 2010-02-12.
- ^ "Wyeth - WYE". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/22.html. Retrieved 2010-02-12.
- ^ "Bristol-Myers Squibb - BMY". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/64.html. Retrieved 2010-02-12.
- ^ "Eli Lilly - LLY". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/259.html. Retrieved 2010-02-12.
- ^ a b "Global 500". CNN. 2008. http://money.cnn.com/magazines/fortune/global500/2008/index.html. Retrieved 2009-07-27.
- ^ Company Structure. 2009. http://www.jnj.com/connect/about-jnj/company-structure/?flash=true. Retrieved 2010-03-03.
- ^ Profile and Organization. 2010-01-01. http://www.bayer.com/en/Profile-and-Organization.aspx. Retrieved 2010-03-03.
- ^ "Pfizer Annual Report" (PDF). 2008. http://media.pfizer.com/files/annualreport/2008/annual/review2008.pdf. Retrieved 2009-07-24.
- ^ "Wyeth Annual Report" (PDF). 2008. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9ODM4NnxDaGlsZElEPS0xfFR5cGU9Mw==&t=1. Retrieved 2009-07-24.
- ^ "Abbott Annual Report" (PDF). 2008. http://www.abbott.com/static/content/microsite/annual_report/2008/support_files/ABT_AR_08_onlinefull.pdf. Retrieved 2009-07-24.
- ^ "Kennzahlen Bayer Konzern". 2008. http://www.geschaeftsbericht2008.bayer.de/de/Kennzahlen.aspx. Retrieved 2009-07-27.